A Strategic Approach to Positioning of Cytochrome P450 Studies and Risk Assessment for Drug-Drug Interaction in Drug Discovery

被引：0
|
作者：
Yasuhiro, Yamada [1 ]
机构：
[1] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Toda, Saitama 3358505, Japan
来源：
16TH INTERNATIONAL CONFERENCE ON CYTOCHROME P450, PROCEEDINGS | 2009年
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：7 / 11
页数：5
相关论文
共 50 条
  • [1] In vitro assessment of cytochrome P450 metabolic drug-drug interaction potential of ciclesonide
    Chu, V
    Zeng, ZP
    Pan, JM
    Wei, YYV
    Rao, ZS
    Chen, J
    King, SP
    DRUG METABOLISM REVIEWS, 2004, 36 : 276 - 276
  • [2] Application of Cytochrome P450 Drug Interaction Screening in Drug Discovery
    Foti, Robert S.
    Wienkers, Larry C.
    Wahlstrom, Jan L.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2010, 13 (02) : 145 - 158
  • [3] PREDICTION OF DRUG-DRUG INTERACTIONS BASED ON CONTRIBUTION OF CYTOCHROME P450 ENZYME TO DRUG METABOLISM USING THE RAF APPROACH IN DRUG DISCOVERY
    Yokoo, Koji
    Tohda, Toshifumi
    Naritomi, Yoichi
    Ueda, Naoki
    Kadono, Keitaro
    Tabata, Kenji
    DRUG METABOLISM REVIEWS, 2015, 47 : 111 - 111
  • [4] Drug-drug interactions and the cytochrome P450 system: An update
    Shannon, M
    PEDIATRIC EMERGENCY CARE, 1997, 13 (05) : 350 - 353
  • [5] Identification of cytochrome P450 isoforms involved in the metabolism of artocarpin and assessment of its drug-drug interaction
    Qu, Wei
    Liu, Xuezheng
    BIOMEDICAL CHROMATOGRAPHY, 2018, 32 (04)
  • [6] Clinical Drug-Drug Interaction Assessment of Ivacaftor as a Potential Inhibitor of Cytochrome P450 and P-glycoprotein
    Robertson, Sarah M.
    Luo, Xia
    Dubey, Neeraj
    Li, Chonghua
    Chavan, Ajit B.
    Gilmartin, Geoffrey S.
    Higgins, Mark
    Mahnke, Lisa
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (01): : 56 - 62
  • [7] Evaluation of Potential Drug-Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P-Glycoprotein
    Zahir, Hamim
    Kobayashi, Fumiaki
    Zamora, Cynthia
    Gajee, Roohi
    Gordon, Michael S.
    Babiker, Hani M.
    Wang, Qiang
    Greenberg, Jonathan
    Wagner, Andrew J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (03): : 298 - 306
  • [8] Drug-drug interaction of acetaminophen and roxithromycin with the cocktail of cytochrome P450 and hepatotoxicity in rats
    Liu, Xiang
    Chen, Chen
    Zhang, Xiaoying
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (03): : 414 - 421
  • [9] Evaluation of Strategies for the Assessment of Drug-Drug Interactions Involving Cytochrome P450 Enzymes
    Reinen, Jelle
    Smit, Martijn
    Wenker, Mira
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 737 - 750
  • [10] In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
    Wang, Lifei
    Zhang, Donglu
    Raghavan, Nirmala
    Yao, Ming
    Ma, Li
    Frost, Charles A.
    Maxwell, Brad D.
    Chen, Shiang-yuan
    He, Kan
    Goosen, Theunis C.
    Humphreys, W. Griffith
    Grossman, Scott J.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 448 - 458
12345